Search

Your search keyword '"Hessamfar, M"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Hessamfar, M" Remove constraint Author: "Hessamfar, M"
112 results on '"Hessamfar, M"'

Search Results

1. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

3. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

5. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

6. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

7. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

8. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

10. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

11. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

12. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

13. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

16. Mortality in migrants living with HIV in western Europe (1997–2013): a collaborative cohort study

17. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

18. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

19. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe

20. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe

24. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

25. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

26. Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study

27. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

28. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

29. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

30. TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

35. Des urines qui « PRES » !

36. Prévalence de l’artériopathie oblitérante des membres inférieurs asymptomatique chez les personnes vivant avec le VIH : étude transversale chez 120 patients suivis en ambulatoire

43. Impact de la non observance au ritonavir, utilisé comme « booster » des antiprotéases du VIH, sur la réponse virologique au traitement

44. Effect of Cytomegalovirus-Induced Immune Response, Self Antigen-Induced Immune Response, and Microbial Translocation on Chronic Immune Activation in Successfully Treated HIV Type 1-Infected Patients: The ANRS CO3 Aquitaine Cohort.

45. Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey)

47. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPART.

48. Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.

49. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies.

50. Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study).

Catalog

Books, media, physical & digital resources